Home/Filings/4/0000950170-25-003024
4//SEC Filing

Kooij Louise Frederika 4

Accession 0000950170-25-003024

CIK 0001936258other

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 5:21 PM ET

Size

5.0 KB

Accession

0000950170-25-003024

Insider Transaction Report

Form 4
Period: 2025-01-07
Kooij Louise Frederika
Chief Accounting Officer
Transactions
  • Award

    Ordinary Shares

    2025-01-07+15,00015,000 total
Footnotes (2)
  • [F1]Represents restricted stock units (RSUs), each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, subject to the Reporting Person's continued service through each such date.
  • [F2]Each RSU was granted on January 7, 2025 for no consideration.

Documents

1 file

Issuer

NewAmsterdam Pharma Co N.V.

CIK 0001936258

Entity typeother

Related Parties

1
  • filerCIK 0002004379

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 5:21 PM ET
Size
5.0 KB